ATE400294T1 - Neue antimikrobielle polypeptide und verfahren für ihre verwendung. - Google Patents

Neue antimikrobielle polypeptide und verfahren für ihre verwendung.

Info

Publication number
ATE400294T1
ATE400294T1 AT98928967T AT98928967T ATE400294T1 AT E400294 T1 ATE400294 T1 AT E400294T1 AT 98928967 T AT98928967 T AT 98928967T AT 98928967 T AT98928967 T AT 98928967T AT E400294 T1 ATE400294 T1 AT E400294T1
Authority
AT
Austria
Prior art keywords
methods
compounds
polypeptides
compositions
new antimicrobial
Prior art date
Application number
AT98928967T
Other languages
English (en)
Inventor
Jeffrey Hillman
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE400294T1 publication Critical patent/ATE400294T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98928967T 1997-06-10 1998-06-09 Neue antimikrobielle polypeptide und verfahren für ihre verwendung. ATE400294T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/871,924 US5932469A (en) 1997-06-10 1997-06-10 Antimicrobial polypeptide, nucleic acid, and methods of use

Publications (1)

Publication Number Publication Date
ATE400294T1 true ATE400294T1 (de) 2008-07-15

Family

ID=25358458

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928967T ATE400294T1 (de) 1997-06-10 1998-06-09 Neue antimikrobielle polypeptide und verfahren für ihre verwendung.

Country Status (10)

Country Link
US (2) US5932469A (de)
EP (1) EP1019084B1 (de)
JP (3) JP4838404B2 (de)
AT (1) ATE400294T1 (de)
AU (1) AU748871B2 (de)
CA (1) CA2295986C (de)
DE (1) DE69839702D1 (de)
ES (1) ES2308806T3 (de)
NZ (1) NZ501658A (de)
WO (1) WO1998056411A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198793A1 (en) * 1997-06-10 2006-09-07 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US6964760B2 (en) * 1997-06-10 2005-11-15 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US6342385B1 (en) 2000-07-28 2002-01-29 The Uab Research Foundation Mutacin I biosynthesis genes and proteins
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
CA2404356A1 (en) * 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
ES2375109T3 (es) 2003-02-03 2012-02-24 General Mills, Inc. Composiciones de masa que comprenden un ácido orgánico encapsulado y un agente antimicrobiano natural.
KR101176660B1 (ko) 2003-08-11 2012-08-23 오라제닉스, 인코포레이티드 구강 건강의 유지를 위한 조성물 및 방법
EP1634948A1 (de) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Mittel und Verfahren zur Vorbeugung und/oder Behandlung von Karies
ITMI20060678A1 (it) * 2006-04-06 2007-10-07 Sanofi Aventis Otc S P A Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
EP2094830B1 (de) 2006-12-19 2013-04-10 Basf Se Anwendungen und verfahren zur vorbeugung und/oder behandlung von durch mutans streptococci verursachter karies
MX353908B (es) 2008-06-13 2018-02-02 Oragenics Inc Uso de bacteria productora de peroxido de hidrogeno para blanquear dientes.
JP5439837B2 (ja) 2009-02-10 2014-03-12 ソニー株式会社 表示装置
US11723852B2 (en) 2011-10-31 2023-08-15 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
AU2012332014B2 (en) 2011-10-31 2017-01-19 Kane Biotech Inc. Compositions and methods for preventing and treating oral diseases
AU2013226402B2 (en) * 2012-02-27 2017-05-18 Oragenics, Inc. Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features
US11206838B2 (en) 2013-04-11 2021-12-28 General Mills, Inc. Batter compositions, packaged batter products, and related methods
JP2017519035A (ja) 2014-06-27 2017-07-13 ケーン バイオテク インコーポレーテッド 抗微生物性−抗バイオフィルム性組成物及び該組成物のパーソナルケア製品のための使用
LU92906B1 (en) 2015-12-14 2017-06-20 Luxembourg Inst Science & Tech List Method for enzymatically modifying the tri-dimensional structure of a protein
US11382885B2 (en) * 2017-06-07 2022-07-12 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031446A (en) * 1958-07-14 1962-04-24 Chattanooga Medicine Co Butyrolactone derivatives
US3968233A (en) * 1973-12-05 1976-07-06 Istituto Chemioterapico Italiano α-Amino-γ-butyrolactones as sedatives
US4474801A (en) * 1982-11-12 1984-10-02 Istituto Chemioterapico Italiano, Spa α-Amino-γ-butyrolactones for treating alcohol dependence
US5837485A (en) * 1988-05-18 1998-11-17 Dr. Karl Tomae Gmbh DNA encoding and biosynthetic process for the preparation of chemical compounds, lantibiotics
NO902352L (no) * 1989-05-29 1990-11-30 Lion Corp Fremgangsmaate for fremstilling av en vaksine mot dental karies, samt vaksineblandinger for anvendelse som nesedraaper
ATE117298T1 (de) * 1991-02-08 1995-02-15 Hoechst Schering Agrevo Gmbh Verfahren zur herstellung von homoserinlactonen.
CA2081704C (en) * 1991-10-31 2007-05-01 Karl-Dieter Entian Biosynthetic process for the preparation of lantibiotics
US5401857A (en) * 1994-02-28 1995-03-28 Arco Chemical Technology, L.P. Process for making γ-butyrolactones
US5872001A (en) * 1994-04-20 1999-02-16 Uab Research Foundation Lanthionine antibiotic compositions and methods
US5650320A (en) * 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
US5607672A (en) * 1995-06-07 1997-03-04 University Of Florida Research Foundation, Inc. Replacement therapy for dental caries

Also Published As

Publication number Publication date
JP4838404B2 (ja) 2011-12-14
EP1019084B1 (de) 2008-07-09
JP2010207227A (ja) 2010-09-24
EP1019084A4 (de) 2001-11-28
NZ501658A (en) 2001-08-31
CA2295986A1 (en) 1998-12-17
EP1019084A1 (de) 2000-07-19
ES2308806T3 (es) 2008-12-01
US6391285B1 (en) 2002-05-21
AU748871B2 (en) 2002-06-13
JP2002504825A (ja) 2002-02-12
AU8064498A (en) 1998-12-30
US5932469A (en) 1999-08-03
JP2009028050A (ja) 2009-02-12
WO1998056411A1 (en) 1998-12-17
CA2295986C (en) 2011-11-01
DE69839702D1 (de) 2008-08-21

Similar Documents

Publication Publication Date Title
ATE400294T1 (de) Neue antimikrobielle polypeptide und verfahren für ihre verwendung.
BR0111718A (pt) Peptìdeos quimicamente modificados, composições e métodos de produção e uso
DE69327645D1 (de) Dna-sequenzen kodierend für neuartige wachstums-/differentierungsfaktoren
DE602004022056D1 (de) Antibakterielle zusammensetzung, vor allem zur bekämpfung gramnegativer bakterien, umfassend ein peptid und ein vorteilhafterweise hydrophobes antibakterielles agens
TR200001203T2 (tr) Yeni birleşik maddeler
ATE189475T1 (de) Wachstums-differenzierungsfaktor der tgf-b familie
ATE251464T1 (de) Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen
AU3973697A (en) Isoxazoline derivatives useful as antimicrobials
FI970810A0 (fi) Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja
SE9802729D0 (sv) Novel Compounds
CO4910133A1 (es) Antagonistas de 5-h[1f]
DE69938935D1 (de) Zyklische conotoxin-peptide
ATE162075T1 (de) Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält
DE69334146D1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
MXPA05008080A (es) Inhibidores peptidicos de toxinas derivadas de la ll-37.
PT1228097E (pt) Actividade antimicrobiana do primeiro grupo cationico da lactoferrina humana
BR9710899A (pt) Composição compreendendo mupirocin e clorohexidina.
BR0312889A (pt) Polipeptìdeo t20 peguilado
SE9802937D0 (sv) Novel compounds
DE60225155D1 (de) 3-substituierte 6,7-dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
ATE285786T1 (de) Säugetierabkömmliche peptide zur behandlung von mikrobiellen infektionen
EP0916670A3 (de) Pyrrolo-(3,2-b)pyridine und ihre Verwendung als 5-HT1F Agonisten
EP0816504A3 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
DK0842193T3 (da) Somatostatin-analoge cykliske peptider med hæmmende aktivitet på væksthormon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties